Nattokinase May be the Cat's Meow for COVID Vaccine Injury and Long Haul
#64 2023 The Rowen Report Addendum
Dear Subscriber,
I thought of putting this into my post moments ago about nattokinase but chose not to, wanting to emphasize its utility for vascular conditions. I friend emailed me about this report which I had read and filed months ago. I think it is relevant to share now.
It appears that this enzyme is effective on the infamous spike protein of COVID. This means it could help those afflicted with long haul, as well as vaccine injured, since spike protein is almost certainly involved.
The article I gave you indicates that some 10K units of NK is very, very effective AND safe for vascular conditions. So, it might be a very reasonable dose to take for COVID related conditions.
Of course, no health journalist can diagnose or treat you in his/her forums. Just educate and provide useful information. You have to make the decision on any information provided by any health journalist. Don’t forget to use discount code for Allergy Research Group’s excellent nattokinase product in last post.
Oh. regarding time to take NK. Likely best on empty stomach for overall activity. However, if a risk for vascular thrombosis, before bed is a good time as being in bed, not moving, is a risk for leg clots. This report from Japan, land of natto, has more information, including utility of taking it before bed to reduce risk of nighttime clotting.
To Your Excellent Health,
Robert Jay Rowen, MD
Molecules
. 2022 Aug 24;27(17):5405.
doi: 10.3390/molecules27175405.
Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2
Abstract
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as a pandemic and has inflicted enormous damage on the lives of the people and economy of many countries worldwide. However, therapeutic agents against SARS-CoV-2 remain unclear. SARS-CoV-2 has a spike protein (S protein), and cleavage of the S protein is essential for viral entry. Nattokinase is produced by Bacillus subtilis var. natto and is beneficial to human health. In this study, we examined the effect of nattokinase on the S protein of SARS-CoV-2. When cell lysates transfected with S protein were incubated with nattokinase, the S protein was degraded in a dose- and time-dependent manner. Immunofluorescence analysis showed that S protein on the cell surface was degraded when nattokinase was added to the culture medium. Thus, our findings suggest that nattokinase exhibits potential for the inhibition of SARS-CoV-2 infection via S protein degradation.
Keywords: COVID-19; SARS-CoV-2; nattokinase.
Dr. Rowen,
I saw a report that Nattokinase was a P-Glycoprotein inhibitor. Could this cause a problem with taking Nattokinase?
Thanks for your excellent work and concern.
Kelly Gordon